MANDEEP DHINDSA: Open Payments
NPI 1609277052 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,765 in 92 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $676 · 2025 $1,765
Food & beverage: $1,765
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $553 |
| Novo Nordisk Inc | 12 | $304 |
| PFIZER INC. | 10 | $209 |
| Supernus Pharmaceuticals, Inc. | 6 | $112 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Lilly USA, LLC | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $56 |
| Astellas Pharma US Inc | 2 | $40 |
Products named: VRAYLAR, NURTEC ODT, UBRELVY, QULIPTA, Qelbree, Auvelity, CAPLYTA, Ozempic.
Industry payments across VA — which companies pay providers there.
